U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

i

Effects of imperfect test sensitivity and specificity on observational studies of influenza vaccine effectiveness

Supporting Files


Details

  • Alternative Title:
    Vaccine
  • Personal Author:
  • Description:
    Background

    The recently developed test-negative design is now standard for observational studies of influenza vaccine effectiveness (VE). It is unclear how influenza test misclassification biases test-negative VE estimates relative to VE estimates from traditional cohort or case-control studies.

    Methods

    We simulated populations whose members may develop acute respiratory illness (ARI) due to influenza and to non-influenza pathogens. In these simulations, vaccination reduces the risk of influenza but not of non-influenza ARI. Influenza test sensitivity and specificity, risks of influenza and non-influenza ARI, and VE were varied across the simulations. In each simulation, we estimated influenza VE using a cohort design, a case-control design, and a test-negative design.

    Results

    In the absence of influenza test misclassification, all three designs accurately estimated influenza VE. In the presence of misclassification, all three designs underestimated VE. Bias in VE estimates was slightly greater in the test-negative design than in cohort or case-control designs. Assuming the use of highly sensitive and specific reverse-transcriptase polymerase chain reaction tests for influenza, bias in the test-negative studies was trivial across a wide range of realistic values for VE.

    Discussion

    Although influenza test misclassification causes more bias in test-negative studies than in traditional cohort or case-control studies, the difference is trivial for realistic combinations of attack rates, test sensitivity/specificity, and VE.

  • Subjects:
  • Source:
    Vaccine. 33(11):1313-1316.
  • Pubmed ID:
    25659280
  • Pubmed Central ID:
    PMC5934991
  • Document Type:
  • Funding:
  • Volume:
    33
  • Issue:
    11
  • Collection(s):
  • Main Document Checksum:
    urn:sha256:6d669617166475b6cbf176951eeda7a236bbd50ea4aa889b6ba763b27d9d384e
  • Download URL:
  • File Type:
    Filetype[PDF - 182.85 KB ]
ON THIS PAGE

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.